Publicaciones en colaboración con investigadores/as de University of Pittsburgh (29)

2024

  1. Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1

    JHEP Reports, Vol. 6, Núm. 1

  2. Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors

    Journal for ImmunoTherapy of Cancer, Vol. 12, Núm. 3

2023

  1. Author Correction: Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis (Nature Communications, (2019), 10, 1, (3126), 10.1038/s41467-019-11004-3)

    Nature Communications

  2. Rescue of infant progressive familial intrahepatic cholestasis type 3 mice by repeated dosing of AAV gene therapy

    JHEP Reports, Vol. 5, Núm. 5

2022

  1. Poor Outcomes of Patients With NAFLD and Moderate Renal Dysfunction or Short-Term Dialysis Receiving a Liver Transplant Alone

    Transplant International, Vol. 35

2021

  1. An Experimental DUAL Model of Advanced Liver Damage

    Hepatology Communications, Vol. 5, Núm. 6, pp. 1051-1068

  2. Super enhancer regulation of cytokine-induced chemokine production in alcoholic hepatitis

    Nature Communications, Vol. 12, Núm. 1

2020

  1. Ethical criteria for the admission and management of patients in the icu under conditions of limited medical resources: A shared international proposal in view of the covid-19 pandemic

    Frontiers in Public Health, Vol. 8

  2. Exogenous Liposomal Ceramide-C6 Ameliorates Lipidomic Profile, Energy Homeostasis, and Anti-Oxidant Systems in NASH

    Cells, Vol. 9, Núm. 5

  3. Hepatic gap junctions amplify alcohol liver injury by propagating cGAS-mediated IRF3 activation

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 117, Núm. 21

  4. Recent advances in alcohol-related liver disease (ALD): Summary of a Gut round table meeting

    Gut, Vol. 69, Núm. 4, pp. 764-780

2019

  1. Alcohol-Related Liver Disease Is Rarely Detected at Early Stages Compared With Liver Diseases of Other Etiologies Worldwide

    Clinical Gastroenterology and Hepatology, Vol. 17, Núm. 11, pp. 2320-2329.e12

  2. Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis

    Nature Communications, Vol. 10, Núm. 1

  3. Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3

    Cell, Vol. 176, Núm. 1-2, pp. 334-347.e12

  4. Histopathological and Molecular Signatures of a Mouse Model of Acute-on-Chronic Alcoholic Liver Injury Demonstrate Concordance with Human Alcoholic Hepatitis

    Toxicological Sciences, Vol. 170, Núm. 2, pp. 427-437

  5. Metabolic consequences of T-cell costimulation in anticancer immunity

    Cancer Immunology Research, Vol. 7, Núm. 10, pp. 1664-1669

  6. Reduced serum sphingolipids constitute a molecular signature of malnutrition in hospitalized patients with decompensated cirrhosis

    Clinical and Translational Gastroenterology, Vol. 10, Núm. 3

2018

  1. Perspectives in immunotherapy: Meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy)

    Journal for ImmunoTherapy of Cancer, Vol. 6, Núm. 1

2016

  1. Emerging opportunities and challenges in cancer immunotherapy

    Clinical Cancer Research, Vol. 22, Núm. 8, pp. 1845-1855

  2. The SF3B1 inhibitor spliceostatin A (SSA) elicits apoptosis in chronic lymphocytic leukaemia cells through downregulation of Mcl-1

    Leukemia, Vol. 30, Núm. 2, pp. 351-360